BIOSTEN, LLC

  • Grant accepted

Project

We developed the technology that enables manufacturing of bioresorbable stents from composite materials to ensure the control over the process of bioresorbtion and to achieve mechanical properties that make it possible for bioresorbable stents to acutely perform similarly to metal stents during clinical procedures.

Market

Global Coronary Stents Market is expected to reach $10.6 billion by 2016 at a CAGR of 8.3% according to BCC Research.


Company

Biosten LLC is established to develop biodegradable implants and commercialize the results of its R&D. The core of the company is comprised of experts in the field of biopolymers, biomedical technologies, medical device development, and includes top managers of international biomedical projects.The company developed a patented and patent-pending biodegradable stent prototype which has passed trials for biosafety.


Team [8]

Egor Vladimirovich Lukyanov
Egor Vladimirovich Lukyanov

Mentor of project "Development of bioresorbable endovascular...

Michael Evgenevich Popov
Michael Evgenevich Popov

CEO Biosten LLC., Ph.D.

Aleksey Borisovich Drugov
Aleksey Borisovich Drugov

Head of Transfer Technology Department

Anna Igorevna Prostyakova
Anna Igorevna Prostyakova

Project Manager, Ph.D.

Elena Nikolaevna Medvedeva
Elena Nikolaevna Medvedeva

Chief accountant

Tatiana Anatolevna Khmelyuk
Tatiana Anatolevna Khmelyuk

Project Assistant


Investors [1]